Evidence map›Paper›PMID 37865628›Full record

ReviewEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2024

Interaction of preoperative chemoprophylaxis and tranexamic acid use does not affect transfusion in acetabular fracture surgery.

Harsh Wadhwa, Matthew Rohde, Yousi Oquendo, Michael J Chen, Seth S Tigchelaar, Michael Bellino, Julius Bishop, Michael J Gardner

Abstract readReview
PubMed Publisher
In one paragraph

Review in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Harsh WadhwaDepartment of Orthopaedic Surgery, Stanford School of Medicine, Stanford, CA, 94305, USA.
Matthew RohdeDepartment of Orthopaedic Surgery, Stanford School of Medicine, Stanford, CA, 94305, USA. rohde.matt1@gmail.com.ORCID http://orcid.org/0000-0003-0511-1183
Yousi OquendoDepartment of Orthopaedic Surgery, Stanford School of Medicine, Stanford, CA, 94305, USA.
Michael J ChenDepartment of Orthopaedic Surgery, Stanford School of Medicine, Stanford, CA, 94305, USA.
Seth S TigchelaarDepartment of Orthopaedic Surgery, Stanford School of Medicine, Stanford, CA, 94305, USA.
Michael BellinoDepartment of Orthopaedic Surgery, Stanford School of Medicine, Stanford, CA, 94305, USA.
Julius BishopDepartment of Orthopaedic Surgery, Stanford School of Medicine, Stanford, CA, 94305, USA.
Michael J GardnerDepartment of Orthopaedic Surgery, Stanford School of Medicine, Stanford, CA, 94305, USA.
Stanford Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWhile the effects of tranexamic acid (TXA) use on transfusion rates after acetabular fracture surgery are unclear, previous evidence suggests that holding deep vein thrombosis (DVT) chemoprophylaxis may improve TXA efficacy. This study examines whether holding DVT chemoprophylaxis in patients receiving TXA affects intraoperative and postoperative transfusion rates in acetabular fracture surgery.

methodsWe reviewed electronic medical records (EMR) of 305 patients who underwent open reduction and internal fixation of acetabular fractures (AO/OTA 62) and stratified patients per the following perioperative treatment: (1) no intraoperative TXA (noTXA), (2) intraoperative TXA and no preoperative DVT prophylaxis (opTXA/noDVTP), or (3) intraoperative TXA and preoperative DVT prophylaxis (opTXA/opDVTP). The primary outcomes were need for intraoperative or postoperative transfusion. Risk factors for each primary outcome were assessed using multivariable regression.

resultsIntraoperative or postoperative transfusion rates did not significantly differ between opTXA/opDVTP and opTXA/noDVTP groups (46.2% vs. 36%, p = 0.463; 15.4% vs. 28%, p = 0.181). Median units transfused did not differ between groups (2 ± 1 vs. 2 ± 1, p = 0.515; 2 ± 1 vs. 2 ± 0, p = 0.099). There was no association between preoperative DVT chemoprophylaxis and TXA with intraoperative or postoperative transfusions. EBL, preoperative hematocrit, and IV fluids were associated with intraoperative transfusions; age and Charlson Comorbidity Index (CCI) were associated with postoperative transfusions.

conclusionOur findings suggest holding DVT prophylaxis did not alter the effect of TXA on blood loss or need for transfusion.

Indexed as

Antifibrinolytic AgentsHip FracturesTranexamic AcidBlood Loss, SurgicalChemopreventionHumansAntifibrinolytic AgentsTranexamic AcidAcetabular fractureAnticoagulantsDVTTransfusionsTXA

Identifiers

PMID37865628
OpenAlexW4387843782

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.